Immunomorphological Analysis of the CD40-CD154 Interaction in T Follicular Helper Cell Lymphoma Emphasizes the Significance of the CD40-CD154 Axis in the Disease.

Dóra Mária Janotka, Zita Borbényi, Klára Piukovics, Mátyás Bukva, Annamária Bakos, Enikő Bagdi, László Krenács

Abstract read

In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dóra Mária JanotkaLaboratory of Tumor Pathology and Molecular Diagnostics, 6726 Szeged, Hungary.

Zita BorbényiDepartment of Hematology, Internal Medicine Clinic South Division, Albert Szent-Györgyi Clinical Center, University of Szeged, 6725 Szeged, Hungary.

Klára PiukovicsDepartment of Hematology, Internal Medicine Clinic South Division, Albert Szent-Györgyi Clinical Center, University of Szeged, 6725 Szeged, Hungary.

Mátyás BukvaDepartment of Immunology, Albert Szent-Györgyi Medical School, University of Szeged, 6725 Szeged, Hungary.

Annamária BakosDepartment of Nuclear Medicine, Albert Szent-Györgyi Clinical Center, University of Szeged, 6725 Szeged, Hungary.

Enikő BagdiLaboratory of Tumor Pathology and Molecular Diagnostics, 6726 Szeged, Hungary.

László KrenácsLaboratory of Tumor Pathology and Molecular Diagnostics, 6726 Szeged, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral T-cell lymphomas (PTCLs) are malignancies of mature T cells with a poor prognosis. Most PTCL cases express follicular T-helper (T

Indexed as

CD40 AntigensCD40 LigandLymphoma, T-Cell, PeripheralT Follicular Helper CellsFemaleHumansMaleMiddle AgedSignal TransductionT-Lymphocytes, Helper-InducerCD40 AntigensCD40 Ligandangioimmunoblastic typeCD40 and CD154 expressionCD40–CD154 interaction in T-cell lymphomafollicular typenodal peripheral T-cell lymphomaNOS typeT-follicular helper cell lymphoma

Identifiers

PMID42121886

DOI10.3390/cells15090785

PMCPMC13162781

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.